Site-specific pharmacology for the treatment of Alzheimer's disease
- PMID: 8282078
- DOI: 10.1006/exnr.1993.1172
Site-specific pharmacology for the treatment of Alzheimer's disease
Similar articles
-
Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.J Neurosci Res. 2004 Jul 1;77(1):94-9. doi: 10.1002/jnr.20134. J Neurosci Res. 2004. PMID: 15197742
-
RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.FEBS J. 2007 Apr;274(7):1715-24. doi: 10.1111/j.1742-4658.2007.05717.x. Epub 2007 Feb 28. FEBS J. 2007. PMID: 17331188
-
Alzheimer's disease: a multisystem disorder.Res Publ Assoc Res Nerv Ment Dis. 1986;64:209-14. Res Publ Assoc Res Nerv Ment Dis. 1986. PMID: 3523660 Review. No abstract available.
-
Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.Neuroreport. 2008 Jul 16;19(11):1085-9. doi: 10.1097/WNR.0b013e328302c858. Neuroreport. 2008. PMID: 18596605
-
Alterations of signal transduction in the lesioned entorhinal-hippocampal system: a mini-review on Alzheimer's disease-related changes and experimental data.Hippocampus. 1993;3 Spec No:131-8. Hippocampus. 1993. PMID: 8287091 Review. No abstract available.
Cited by
-
Alzheimer's disease: fundamental and therapeutic aspects.Experientia. 1995 Feb 15;51(2):99-105. doi: 10.1007/BF01929348. Experientia. 1995. PMID: 7875258 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical